Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein
KEYWORDS: people, vte, prophylaxis, risk, vte prophylaxis, surgery, lmwh, use, risk vte, pharmacological, consider, bleeding, undergoing, people undergoing, person

first-line treatment. • If LMWH is contraindicated, use fondaparinux sodium. [2018] In March 2018, the use of LMWH and fondaparinux sodium in young people under 18 was off label. See NICE's information on prescribing medicines. Head and neck surgery Oral and maxillofacial surgery 1.14.11 Consider pharmacological VTE prophylaxis with LMWH for a minimum of 7 days for people undergoing oral or maxillofacial surgery whose risk of VTE outweighs their risk of bleeding. [2018] In March 2018, the use of LMWH in young people under 18 was off label. See NICE's information on prescribing medicines. 1.14.12 Consider mechanical VTE prophylaxis on admission for people undergoing oral or maxillofacial surgery who are at increased risk of VTE and high risk of bleeding. Choose either: • anti-embolism stockings or • intermittent pneumatic compression. Continue until the person no longer has significantly reduced mobility relative to their normal or anticipated mobility. [2018] ENT surgery 1.14.13 Consider pharmacological VTE prophylaxis with LMWH for a minimum of 7 days for people undergoing ears, nose or throat (ENT) surgery whose risk of VTE outweighs their risk of bleeding. [2018] In March 2018, the use of LMWH in young people under 18 was off label. See NICE's information
